{"title":"严重的口腔黏膜炎:公司把钱花在口腔上,争夺市场份额","authors":"Bryan Oronsky, Babak Alizadeh","doi":"10.14229/onco.2023.09.02.011","DOIUrl":null,"url":null,"abstract":"At one point only a few short years ago several more were in the race to be approved for severe oral mucositis (SOM), which refers to sores or ulcers that develop in the mouth and throat. SOM is the most serious and common complication from the management of head and neck cancer, a highly curable cancer if detected early and treated fully.","PeriodicalId":496622,"journal":{"name":"Onco'zine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Severe Oral Mucositis: Companies Put Their Money where the Mouth is and Vie for a Marketshare\",\"authors\":\"Bryan Oronsky, Babak Alizadeh\",\"doi\":\"10.14229/onco.2023.09.02.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"At one point only a few short years ago several more were in the race to be approved for severe oral mucositis (SOM), which refers to sores or ulcers that develop in the mouth and throat. SOM is the most serious and common complication from the management of head and neck cancer, a highly curable cancer if detected early and treated fully.\",\"PeriodicalId\":496622,\"journal\":{\"name\":\"Onco'zine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Onco'zine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14229/onco.2023.09.02.011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onco'zine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14229/onco.2023.09.02.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Severe Oral Mucositis: Companies Put Their Money where the Mouth is and Vie for a Marketshare
At one point only a few short years ago several more were in the race to be approved for severe oral mucositis (SOM), which refers to sores or ulcers that develop in the mouth and throat. SOM is the most serious and common complication from the management of head and neck cancer, a highly curable cancer if detected early and treated fully.